Deliberations Continue in Latest Hormone Replacement Therapy Trial

After an hour of deliberation Friday and four weeks of trial, a Philadelphia jury will continue its work today in a lawsuit over whether drugmaker Wyeth's hormonal drug caused an Alabama plaintiff's breast cancer. An attorney for the plaintiffs alleged during closing arguments that Wyeth was negligent in "experimenting" on "grandmothers" because of its failure to adequately warn doctors and patients of the increased risk of breast cancer from using its hormone replacement therapy drugs, including Prempro.